Prollenium US
Sharon Bennett has extensive experience in the aesthetic industry, holding key roles since 2006, including Director at Harrogate Aesthetics and Clinical Lead for Aesthetics Media. Bennett serves as a KOL and Trainer for Prollenium while chairing the BACN, providing leadership and strategic direction for the board. Additionally, Bennett participates in the BSI committee for CEN/403 Aesthetic Surgery Services, advocating for standards in aesthetic practices, and previously led initiatives for non-surgical cosmetic standards. Education includes a Level 7 mentorship from Northumbria University and an MSc in Non-Surgical Cosmetic Interventions, reflecting a strong commitment to professional development in aesthetic nursing and management.
This person is not in any offices
Prollenium US
Prollenium US is the US division of Prollenium Medical Technolgoies Inc.—a Canadian manufacturer and distributor of HA dermal filler. We are proud to address all of our client's needs through streamlined medical device innovation. Prollenium is able to ensure a continual flow of creation, unique ideas, and a steady pipeline of new and exciting products that provide safe and effective results. US FDA, Health Canada, and CE approvals, over 4 million syringes in the Revanesse product line have been sold to 80+ countries world-wide. Prollenium is the only manufacturer of Hyaluronic Acid dermal fillers in North America. Join our dedication to innovation.